Stay updated with breaking news from Ck Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
<div> HONG KONG SAR - <a href="https://www.media-outreach.com/">Media OutReach Newswire</a> - 5 April 2024 - CK Life Sciences Int’l., (Holdings) Inc. will be presenting new data from its cancer vaccine research pipeline at the 2024 American Association for Cancer Research (AACR) Annual Meeting in San Diego, California, USA.</div>
/PRNewswire/ -- XtalPi, a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking...
/PRNewswire/ -- Pharus Diagnostics ("PharusDx") today announced a global exclusive license agreement with City of Hope cancer center for proprietary biomarkers...
Xtalpi’s last private fundraising was a $380 million Series D round in October 2021 that valued the company at about $2 billion.
Today, XtalPi, a leading global technology company in combining artificial intelligence (AI) and robotics to drive the discovery of groundbreaking medicine and innovative materials, announced the signing of a new agreement with CK Life Sciences, a member of the CK Hutchison Group. Expanding upon their existing partnership, the two companies will combine AI algorithms with anonymized clinical and biomarker data from cancer patients and healthy individuals in CK Life Sciences' data repository to j